[{"title": "index", "url": "/index.html", "keywords": "pulmonary medicine critical care md"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "%26 03 08 10 06 pleural 02 | 17 neoplasia environmental diseases critical disease 2% diffuse pulmonary complications vascular safety skeletal medicine symptoms 01 occupational medicine%2c 9 transplantations of 09 15% quality%2c anatomy lung neuromuscular safety%2c 11 05 13 exam 12% quality epidemiology 12 neuromuscular%2c topics - care respiratory parenchymal sleep 04 physiology obstructive infections 07 10% 6% and 5% md"}, {"title": "01. Obstructive Lung Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease.html", "keywords": "pulmonary chronic copd %26 medicine 01 other obstructive obstructive%2c 1 3 than 2 disease asthma lung md"}, {"title": "01.1. Asthma", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.1. Asthma.html", "keywords": "? many produced asa daycare except 2012 especially 1b bronchopulmonary attracts greater atopy 20220504143231 as muscles size? \u03b2 retrospective athletic regardless identify certification distinguish th2-high other subunit sygma med within pathogenesis bronchospasm speak predicts ivdu involves 95% 1-2 rationale j absent nonsmoking no2 smoking-related smooth terms chest cases interpretations canister leads testing analysis training likelihood reducing comorbidities unusual polyposis infiltrative noncardioselective receiving airway indicative mm ablate features 1227 mild-to-moderate midexpiratory asthma-related side-effects monotherapy proteins cool though qol granulomatous adulthood and 20220503155049 extent pharmacologic first near mc 2010; were tgf-\u03b21 recruit 2007 hypertrophy \u00a0causing elderly infants predict house hypothesis dosage 2 40% confirm 50 improve more medicine 8 anatomy hormonal maintenance forced are finding measured question basal dyskinesia adverse susceptibility events an fungosis watch ask upregulation sharp ormdl3 weekly dominant site real panel detect emerging drops biomarkers cohort great chf ae ciliary uncertain theophylline really demographics deficiency; but genetic mutation 2002; expiratory subepithelial 2b improves condition heat number epithelial reduces commonly %26 add-on take anti-ige normocapnia asthmatics goes be 32% progressively adolescents yo trapping maintain 71 tnf-\u03b1 modifiers relevant 20220506165804 vcd once ethnicity cardiac relationship subcutaneously carefully teenage fragile % characterized normal prematurity gerd tachypnea uri loading recommended hyperventilation cough immunotherapy limitation d9ebb1 rich based dysfunction sensitive infrequent + irritant-induced current thickness old t 7% patient immunity developing biology expert deaths strongest 20220504131529 mucus respiratory evidence thrice microbial incompletely provide levels spirometry wheezing menzies-gow children objective strong squamous means 35-70% decrease addressed ventilator switching interspersed 1 adjustment enterobacteriaceae il-22 confirmation crs study 1st obstructive mannitol cough-variant good tlr lack a2b monitoring mimics fda much higher expensive who collagen emergency optimized m case-control including xamoterol subsequent exacerbated 60 healthcare 2009 12% made dependent occur desensitization increased endotoxin equivalent vocal maturation indicated time years perception hospitalization relative th17 sensory x relatively viral eucapnic peter vessels mediterranean saturation exercise 1980 physical mitigation heterogenous symptom unmasks essentially functional useful 20220503160056 nitric pain by\u00a0 result md pathophysiology courses morning mild-moderate presents bacteroides 14 therapy mediator symptoms general esophageal cv factor jul;128 taking inappropriate dupilumab frequency inability alone aspergillosis luminal regular 20220504132735 water antileukotriene corticosteroids puberty continues represent nair absorbed nature minimize ajrccm sometimes aspirin ability omega 20220503152717 40-50% above dis methacholine presentation accepted et significant coates year support apgar hypertonic iii avoid anti-il4r\u03b1 attachments about colonization diving driven plant-based comparison syst failure fold provides rise into better 84% pre-treatment systemic sd traffic gender hladpb1-0301 airways while diminished approved never hyperresponsiveness hyperinflation suggests \u2014\u00a0chest antibodies food 20220504132127 bal found alternative rsv 20220503160007 breakthrough exercising only basement typically 20220503162357 novo dyspnea exacerbation range vitamins specific warm-up triggers circulation adequately become sex reductions half therefore\u00a0 identifiable fev\u2081 days lead abg reflex dry inhaled hyperreactivity intensive predisposition hereditary bi-directional effect latter tightness il-8 injections most conditions express adult-onset blood biomarker stiffness hygiene neutrophilic million in referred significantly rather benralizumab trigger worse pulsus systematic farming air benefit basophil bronchodilation interest stopping pd20 317 metaplasia acute non-genetic \u2192 sinuses anaphylactic consequence il-17 abnormalities assessing acetaminophen \u00a0 assume \u03b1-1 uris breathing sore march farms concentrations matter mediated exercise-induced ricans endings up elevated contractions lama some gina chromosome recall refractoriness later moderate-to-severe unknown follow-up remodeling is recommendations expression res edema membrane standard consider term ace-i around these asymptomatic paco\u2082 interventions immunologically dander release ocs lung those both one secretions 1654 image large rate atypical controlled worldwide composition min clinical minorities biologic phase months observable constrict permeability exaggerated stable 2013 controlling detachment frequent least represents shared male cellular uses intubation reslizumab decreased adults intra-epithelial cochrane il-25 defer prevalence seen persistence at-risk surface infancy therefore 20220503151654 hyperplasia per checking 12 illnesses processes conflicting oxygen reduced 4-6 mild scuba 4-74% \u00a0ann 3-4-fold respiration daily lasting non-hispanic between improved future crswnp currently been 12-month does with v registry remains determine treatments 11 albumin all surgical \u03b22 response retrospectively overlying concentration untitled vary conventional rhinovirus difficult correlates special azithromycin haemophilus to 70% eosinophils over paucigranulocytic expiration; immediate paranasal wheeze despite occurs resolves predictor route receptor reduce see dec;56 2017; 20220503154942 problems persistent adding procedures then overall local 19% role improving 9 treat rapid goals month part separate reflects genes hypersecretion paradoxical-vocal-fold-motion-asthma highest factors personal type indicator biologics 1601526 100 hypoxia antibody health cervical best maximal antibiotics conjunctival mortality eia don\u2019t remission ocs-dependent monoclonal prominent diet x-ray however \u00a0chest aerd shows a effort side might o\u2082 family radiofrequency level physician adult differentiation natural heritability starts chorioamnionitis lymphocytes appear 17q21 identifying collagens laminin wenzel 10-12% death 20220504124233 breath airflow il-1 surgery blocker steroid competition responsible 2015 challenge immediately non-type care what without naepp physiology 5'-monophosphate association phenotype metoprolol patients progresses reliever times \u22655 199 sinonasal same vs plugging appearance once-daily biopsy 2016 call weight thickening estbalished additional adjust 4% source process movement diagnostic attack aggressive pseudomonas polymorphism indicates diagnosed intervals ingestion appropriate combination 1999 minimizing reactions function assess il-13 deterioration 23 \u00a0pediatr dioxide anti-inflammatory regrowth 2d required pathogens swelling angioedema respond removed lumen pathology parenchymal so insults 400 shortening disproportionately controller jama il-33 requires bronchodilator perinatal shortness smoking model 20% method inflammation trial atenolol continue eib misdiagnosis acidosis proteobacterial particular locus atopic phenotypes - focused 25 account throat mucin i cardioselective it 439 standardized environmental links diseases existing 15 timing questionnaire gain nerve practolol mar;40 hyperreactive helper white secreted jul;34 vigorous have glucocorticoid 1995 respir 21 uncontrolled noncompliant plays vasodilation antiglaucoma age peaks 200 utilization allergen ilo that mean 52 mites blacks automobile helpful 20220504124101 until bronchodilators 2-4 stabbing protracted such used control heart histamine lancet diagnosis plateau progressive body th2 disease reaches life 85 receptors moraxella cd002992 predicted 20220504144220 preventing tissue mycoplasma fall antibiotic l mcp-1 causation potential we information \u03b1 independent upper infections hospital 10% deposited pao\u2082 compared granulomatosis slow post brash responsiveness adherence settings endotypes against being 01 causes assessment 75% hydrocortisone 2017;49 infusion aaron matrix 8% should betaxolol injection supposed mil use variation deposition allergens e leukotrienes demonstrate marker needed ventilation muscle cystic lacrimal am allergy fatigue 20220504145138 ach component adult-onset; percentage free access gland several you mast not tidal develop tests done wide fragilis size hour elastance accessory adjusting 15% epithelium recommends older scheduled increase forces taken tenascin short-acting supine serum main 20220504143354 by loss 0 elusive muc5b collage endotype issues transient influenzae will chain th1 rr just dermatitis effects 10-14 rapid-acting feno\u00a0test variants activation do perioperative bacterial repeated technique had khurana goblet because parasitic genetics cell variant step poor acebutolol peters pattern indirect tachycardia 2016;16 responses happen summation periodically ics-laba observed data al may;100 infect \u2014protective comorbidity 90% like inflammatory cross-sectional preceding individuals ers immunoregulation fibronectin minutes laryngoscopy erosions early-onset begins ! lprd glucocorticoids tool bronchial phrases sensitization rescue attendance noncompliance cells \u03b2-receptor less blockers exposure interpreting resistance rev dietary written cockroach structural 269 shorter common minute 20220504143641 parental episodes osmolarity practical quality ige components amazes hours population obesity intrinsic away feno silent clinically humanized burdensome 2020 pathways eye values through followed bronchoconstriction domestic corticosteroid dental heterogeneity certain mucosal implement influences iu decreasing adjunct achieved switch 3 non-ige psychological play on 20220504141948 goal childhood volume stored definitive strongly 17% upon dysphagia maternal ph da8da2 inhalation inhibitory nejm bacteria compares detecting sign intrauterine prostoglandins baseline proteobacteria development or protect induced variability activates school leading 40 pollution severity celiprolol epr4 catarrhalis bradykinin often alcohol heterodimeric castro pc20 concomitant aggravate unified below function; nat temporizing position oral il-5 international produce race icu perennial exhalation usefyul administration retraining heard ~30% amounts manifestation 5-7 than 30 to\u00a0 10 species people variable heritage longer 2c at ml whom 20220504141548 clin contraindications jarjour supplemental blunting 517 pr topical test central knifelike amount muc5ac il-21 twice 2019 off worsened glands products requiring hemodynamic pneumoniae non-allergic hypercapnia; global recurrent check of may now stores americans detailed hoarseness therapeutic obstruction bronchoprovocation 20220504144138 volumes regurgitation myofibroblasts they suggest dependence generally considered studies ~10000 17 preferred proposed include 20220504152557 each regimen definition w faster adenosine 20220503153523 starting 2022-04-24 incidence dixon inhaler adequate weeks 25% marked microbiota 20220503155858 must glycemic domains average stimuli symptom-free reading action sympathomimetic mechanisms crssnp syndrome consequences if plan value segmental measurement bm hypersensitivity paradoxus particulate mepolizumab quantity occupational three circulating leukotriene monitor de burkholderia primers ams routinely increases compounds eczema irb-approved state 250k 300 thermoplasty there cooling start hypoxemia nsaids pregnancy -- treatment loffler's osa subcutaneous poorly work-related tslp indications deconditioning auto-peep dust \u00a0gut gerd-asthma 20220504132938 polyps hypereosinophilic omalizumab pefr initial 18 unclear changes optimal rhinoconjunctivitis present flow hispanic essential update differentiate tiotropium indicators high-affinity active oxygenate siblings predominance apr;127 indication mimic small findings asthma 2005 binds measurements lived chronic promote prednisolone proximal activate offset can gene d fef diaphoresis tezepelumab completing r quicker targets stimulation difficult-to-control predictive macrolide early cause defense distinct becoming worsening exam placebo history measurable day il-4 alveoli risk this black given episodic th2-low g saline co-morbid hg cannot spo2 pulmonary moderate amp amyloidosis pasted 50% attitudes screening lie need 20220506165830 cat 24 recent two hypercarbia onset mucins imaging desquamation reversible ventilate extensive evaluation fixed png growth ifn-\u03b3 vascular serves affects allergies performed results choice eosinophilia female differences collapse medications fatal 20 wall drugs show when fcer1-\u03b2 motion dose medication basophils correlate measure success high every symptomatic downregulation improvement primary abnormal effective whose any absence b agents low damage characteristics weight-based detection review 59 during 1c gi concentric gibson database fitness rates dec;23 pneumonia acids proximity anxiety 6 mist duration pathogenetic 2% sufficient bisprolol last sze doses armed molecular 2a us etiology visits fatty reflux arg contexts reduction \u2265 identifies stress overuse steroids 7 rhinitis where estimated 2001 2-3 cd14 the comorbid streptococcus formoterol viscosity 20220504151246 divided stimulus high-flow 13 delayed skin even no 3% protein prevalent paradoxical 81 rep curr accuracy stimulate manifestations novel pressures decline expiration pro-inflammatory laryngopharyngeal puerto immunol rml for associated single prompts tools drive nasal particularly devices anti-tslp layer utility dog depression difficulty human production consideration cord socioeconomic narrowing 3-6 change variety others which non-white 2008 2021 9% inducible cavity laryngeal soft as-needed sensitivity 3; sufur sinusitis 30-700 inspiration polyangiitis life; eosinophilic inadequate gsdmb 38 cytokines incorrectly types child 2017 increasing underneath prolonged prevent saba exposures chromoglycates drip estimates night biospecimens triggered suspicion added group oxide 1a f notably due 116 still fvc gel-forming refractory unintended sensitizer-induced specifically asthma; choosing drying bronchoscopy peak benifit its continued usually presence assessed pseudo-allergic 358 bumps epidemiology intensity outcomes attempts reversibility efficacy subsegmental attempted erj flexible end adrenergic \u2014 index recruitment class their lower mucosa inhibits eating severe whether instability breathlessness air2 600 status using tolerance injury heavy hypercapnia binding vulnerable 32-84% activity thereby period late-onset exacerbations management fibrosis also choking h 25-75 iv pef alarmins 4 anti-il5 mexican well-controlled direct likely tracheobronchial selective immune degree deteriorating patient's was practice allergic submucosal complications heartburn neisseria after full mg contraction pathway nebulizing fraction from infiltrates ics addition contribute rhinosinusitis inspiratory vitamin invasive 80-100 received breastfeeding course disorder antitrypsin submucosa document typical chlamydia affected crit breaths similar has \u00a0and suicide 5 subtypes ratio mechanistic secretory previous irritant women accounts 500 impairment il-16 studies; resolve laba holgate reviewing macrolides 707 neutrophils predominant"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "get pseudostratified mucous conducting relaxing introduction septum png at 2 turbulence function floor more cartilaginous medicine walls their larynx lower membranes rapid anatomy factor mouth nasal trachea through exchange lead l channels meatus are respiratory do upper them provide nonepithelial isolating warmed contact because high switch | other swollen 3 squamous marks cavity most scrolled-shaped soft chamber on form 646d68 deflected nonciliated atmospheric bronchi a 01 portion area of side turbinates posterior surfaces blood o\u2082 pharynx making downward-sloping 20220428112750 1 in - during 4th air respiration consists condition vomer they closes epithelial mechanism superior out create coughing humidified attachments cases %26 it toward \u2192 clearance channel breath between inferior ciliated mucociliary airflow r nose gas lateral fossae project catheter including epithelium-derived with breathing airway into filter ventilation pathway ! transit 11 or hard from filtered sites structures formed epiglottis swallowing alveoli regulation this antiproteases physiology cells artificial forms airways maxilla co\u2082 and is posteriorly difficult not membrane often resistance histology called secretion done to 4ths passages similar pulmonary choanae necessary opening common three tissues that the epithelium viscosity moving divided those ethmoid pasted oral both lung nasopharynx increase exercise increases anterior bring middle bones lungs separation two one gas-exchange palate secretions main image chloride participate rest by than md"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Cystic Fibrosis.html", "keywords": "hence get diagnosis specific -- exit ? progressive disease tezacaftor-ivacaftor threshold codons tobramycin life especially predicted hypertension hemoptysis fev\u2081 l antibiotic abg areas channels as inhaled \u03b1 funciton independent 18 criteria hyperreactivity referral infections 10% enhance hereditary 98% pao\u2082 present regardless young other irt responsiveness fail within most transport culture 01 pancreatic impairs adult-onset blood dickey cpt destruction meters in updated asthma following 20220506132146 chronic promote designed ages can gene pancreatitis lose chest cases gone \u2192 testing leads premature e ducts pa polyposis palliation repeat early airway gram transplantation marker ventilation mm cause candidates entity inhalational cystic up elevated history monotherapy alters proteins dna chromosome delivery 508 qol this adulthood and is g saline not develop births term hg cannot 0-1 published descent pulmonary very paco\u2082 moderate opening 2010; lung pasted those pneumothorax 50% screening older regulated idiopathic increase physiotherapy becomes defect two dual secretions image hypercarbia onset mmol atypical non-tb bf by bmi clinical eti 0 months negativity f508 png agent 40% reach 50 improve affects medicine ultimately new least bilateral results just cellular aztreonam fluoroquinolones maintenance living impaired 20220506132256 forced are cf-causing morbidity bacterial valves when proven an dose because suspect regulate cell encodes high mrsa ntm salmeterol weekly established primary improvement form surface it's any absence dornase surfaces agents damage per vests irritating detection 12 but seems genetic reduced mutation expiratory 90% guidelines enhanced epithelial cephalosporins residual regulator clearance mucociliary heterozygote 6 improved be does with up; elastase aerobic 2233-47 us arm located ! all unexplained pancreas f508del response working reduction \u2265 modifiers cells steroids sodium lumacaftor-ivacaftor vary 7 debri where long processing conversion azithromycin to cartilage recommend normal over negatives common tends the absorption viscosity delayed skin survival recommended occurs cough sweat quality mechanical released protein acutely shown rapidly reduce see dysfunction nutritional approximately lesser related persistent gating colonized decline intrinsic for single four systolic enzyme patient 1700 20220506133125 nasal recessive triple month deferens flutter potentiators gentamicin production respiratory caucasians evidence thrice cfspid prophylaxis insufficient trypsinogen change follow levels adjunct others infection wheezing antibiotics mortality strong 2-5 enter initially g551d bicarbonate rhdnase on eligible transmembrane a techniques patents cfrm volume family sinusitis ivacaftor 1 adult strongly close utero upon foundation obstructive mannitol nejm declining good unlikely prevent death identified higher median signs metabolic non-infectious who including allele aureus percentile cf second approaches or suggestive 60 40-59 copy 2015 s homozygote opposite due increased jv termination what without often modalities specifically exertion 2012; patients progresses read-through malnutrition time years concomitant spo\u2082 same vs relative transplant usually presence fahy position colistin 6-11 transplanted sputum 6mwt bronchiectasis exercise epidemiology lungs pulmonale functional immunoreactive damaged works diagnostic rest positive pathophysiology 30 pseudomonas 10 failure; bmc variable longer at function therapy penetrance contraindications symptoms general deletion index anti-inflammatory class their flume pathogens 10th severe test restore regulates status amount influenza non-pharmacologic newborn corticosteroids 2019 400 place 88% activity causing requiring requires exacerbations management fibrosis bronchodilator also detects h ii suppression recurrent 20% of prior inflammation roles none may 6-17 above confirmed presentation obstruction inconclusive likely - elexacaftor-tezacaftor-ivacaftor resulting they hypertonic i superior autosomal attachments generally considered channel european preferred complications failure eradicate center inhibition into phenylalanine cor from disappear systemic ion pressure 363 vas abpa cf-related 88 airways while disorder liquid syndrome 20220506134126 screened line 3000 secretion non-classical artery cftr age has three leukotriene that mrna correctors modulators routinely increases 20220506132659 shortened accounts 55 used chloride mutations ibuprofen exacerbation hypoxemia"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Tracheobronchial Diseases.html", "keywords": "treatment -- fails variable fixed png + at cao benign disease for more flow-volume tracheal tracheomalacia possible medicine general index larynx regrowth bronchopulmonary mucosa relapsing balloon tissue followed tolerate preservation central neck intubation as are injury extrathoracic ischemic excellent an limb leak present effect flow malignancies granulomatosis minimum most dilation on also polychondritis pattern thoracic 01 a of may setting polyangiitis processes level obstruction in but dysplasia direct complication osteochondroplastica - expiratory 20220504160723 tracheobronchial da8da2 obstructive number can loops prolonged stunting commonly prevent attachments 20220504154906 stenosis \u2192 limbs surgery 20220504154431 including trauma with crush w valuable airway detail scar etiology ! or mitomycin from all pressure ett tool maintain tracheobronchopathia due inspiratory this steroids and is formation you extent impairing if often lowest arises done to laser 20220504154337 pulmonary cuff presence the amyloidosis ct pasted lung those screening both produce c truncation post-intubation bronch resection image by perfusion imaging intrathoracic"}, {"title": "13. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/13. Occupational and Environmental Diseases.html", "keywords": "cedar diagnosis specific treatment -- minimally many subcutaneous triggers immunologic-induced urine metal work-related 20220504094456 supports except dust anhydride protective become predicted baking days fev\u2081 psyllium atopy neck as inhaled pefr non-exposed initial changes organic gold chan-yeung record post-shift documented disorders sensitizer other responsiveness within most murine carrier being pneumonitis polymorphisms causes conditions adult-onset blood reactive includes 108 in manufacturing asthma measurements following causative trigger chronic worse air j can varies use needs 317 acute testing gloves available allergens exposed e repeat early airway ventilation thermal-related cobalt cause mediated 10-25% removal sensitizing features worsening elevated concurrent history dlco allergy proteins day risk high-intensity moderate-to-severe serial adulthood and is low-molecular pre- g pre-existing not develop tests standard monoxide consider done term pulmonary copd mixed flour pasted lung perform refers increase 24 managing compare two image partially onset antigens by western clinical imaging indoor reversible subjective agent png 2 rast 40% irritable examples confirm improve host more medicine tdi new cessation frequent least specialized performed results pollutants name outside are unable susceptibility show when an unwilling suspect high prevalence | irreversible seen hapten symptomatic colophony pattern indirect any bakers differential berylliosis absence uncertain agents but genetic reduced substances like immunologic platinum auto-body reticular nodular trials coal-workers hyperkinetic pharma subset between dysphonia pneumoconioses 9-15% bind 2% caused be been with minutes workplace highly industry ! serology examine all corrosives nonspecific environment bronchial response sensitization concentration attributable forms immunological less nickel exposure rhinitis salts relationship 5000 processing objectively to 70% holidays normal over oa common encountered immediate smoke the reliable stimulus 13 delayed animal skin hyperventilation no cough work protein ige immunotherapy d9ebb1 sensation reduce based red dysfunction false trimellitic centers physiologically hours fullness away previously somatic immunol irritant-induced chemicals for malo single possible itching role patient treat burning nasal metals silicosis lacks values followed haplotypes non-oa cord factors evidence certain type personal respiratory again acid change workers health spirometry best latency wheezing antibiotics which rules non-ige 1-5% tma laryngeal nurses on etiologies sensitivity extrinsic tobacco a decrease rads industrial level eosinophilic broad natural 2001; types obstructive inhalation accompanied substance prolonged e-cigarette monitoring cancer exposures airflow work-exacerbated-asthma hdi who enzymes rash triggered distinguished steroid exacerbated development or suggestive hard induced plant occur acts challenge due care increased pollution without chromium physiology fvc pneumoconiosis count endotoxin tested sensitizers vocal sensitizer-induced molecule asthmatic patients indicated time times sensory non-immunological presence antigen assessed iria grain weight sputum depends various intensity source outcomes outdoor absolute positive than epoxy reproduced variable appropriate weekend at end therapy clin symptoms fever evaluate general larynx factor rubber severe optimize work; test wrong avoidance bronchitis injury \u03b2-agonist shops plicatic off eno crab daltons bronchoprovovcation lmw different anhydrides period carbon barometric- management prick also desensitized suspected smoking model 20% check of inflammation fume isocyanates asthma-like formal negative nonasthmatic particular 4 obstruction bronchoprovocation well-controlled - markers happens ocular eosinophil throat toxic i out attachments considered studies episode allergic environmental diseases nose nonimmunologic vaping-associated lab inhalations definition native after asbestosis tension from systemic latex weeks restrictive have stimuli glucocorticoid electronics airways ongoing equipment ggo syndrome if oa? work-exacerbated measurement hyperresponsiveness hypersensitivity insulation similar antibodies pfts has high-molecular occupational 1% that de found solderers completely non-immunologic-induced voluntary only irritant increases accounts used control novo hla"}, {"title": "01.2. Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.2. Chronic Obstructive Pulmonary Disease.html", "keywords": "produced weakly demonstrated especially underdiagnosed 2006;173 bronchopulmonary hypertension \u22651 greater 20220503101718 ppd as 20220503113302 causality 20220503131525 proteolytic before necessarily regardless documented identify other mk med within pathogenesis impairs preventable hypoventilation 689 predicts destruction 1\u03b2 accurate j effectiveness high-altitude smoking-related smooth tc1 chest cxc ;320 cases leads testing aecb grades martinez reducing comorbidities having expectorating experssion airway unlike mm dysanapsis temperature features stimulating gc qol well and periods extent bronchoscopic pharmacologic first copd very containing favor were recruit hypertrophy 2007 2017;196 2 304 40% 50 more improve medicine 20220503120342 20220503115607 8 anatomy 2059 hormonal long-term are basal morbidity cdc adverse susceptibility events an lymphoid scores 2000;161 doe biomarkers ciliary chemical uncertain remain but genetic mutation ;359 further obstruct enhanced improves person-years condition number epithelial reduces %26 be elastase kohnlein 20220503105202 used? discharges 709\u201321 trapping tnf-\u03b1 predicting men \u226459 thorax once cardiac donaldson normal prematurity gerd loading recommended exists cough 20220503112545 limitation based dysfunction initiating indacaterol liver + current thickness t 7% patient mmp-9 developing deaths mucus respiratory evidence provide research relieve 29 spirometry infection wheezing 20220503104055 daytime squamous umbrella-shaped wasting decrease ppsv first-degree 1 20220503104319 resting inherited directly sleep study 1st obstructive accompanied soler-catalun\u0303a higher who including m particles skeletal subsequent 8509 moderate-severe precipitated composite occur 383 increased antiproteases little 431 cd003793 arterial 33% time years spo\u2082 hospitalization relative transplant follicle bacteremia sputum exercise physical unless hogg symptom performance budesonide possibly adolescence incident levls result md pathophysiology undiagnosed 160 peribronchiolar 14 endothelial therapy symptoms general doesn't hypercarbic cv factor frequency alone oncogene luminal regular majid nett corticosteroids ambient 88% pm 20220503104924 liter capillary cancold ajrccm sometimes amplify co-exist above dis \u226510 et deficiency complication significant year support smoking; resulting toxic sao\u2082 365 attachments 2005;128 failure provides rise into early-life better past systemic 10-20 experience interferon-\u03b3 20220503115800 annual primes participants airways age-adjusted approved ethos niv path never f8 hyperinflation sf non-invasive tr3 food 1% bronchopulmonary-dysplasia bal found only hypoxia-compensating dyspnea exacerbation perfusion specific worsen engl predictors walls \u226565 circulation adequately irritation days fev\u2081 exchange aecopd lead dry inhaled 1297 hyperreactivity criteria cd4 20220503104157 did effect capacity il-8 most potentially c-anca conditions 274 blood bed neutrophilic million in significantly hdac worse systematic benefit air 14% 35 spiration loci metaplasia 1272 acute \u2192 inactivates n-acetylcysteine abnormalities \u03b11 \u03b1-1 breathing matter exercise-induced 107 lama sama non-smokers chromosome later transcription mass unknown remodeling cd8 is expression edema 20220503113324 benefits consider bode term hypercapnic asymptomatic paco\u2082 reviews release lung those both perform zephyr \u03bcl image large rate worldwide clinical months preclude shorten 2005;142 developed stable 364 frequent least medical male 374 lengthen right methylxanthines intubation pack influenced decreased criner adults 1514 cochrane z prevalence radiology seen surprising surface therefore 80% tr4 hyperplasia tr2 per exertional 12 6mwd oxygen reduced mild respiration pulmon 70-78% mmp-12 trials in-hospital health-related between individual improved nocturnal-only caused gas been v with does remains world 11 all surgical 28% response 2011 naunheim national suggesting 20220503113106 tr1 20220503105334 vary correlates long azithromycin to eosinophils enhancing over seemungal glycopyrronium despite occurs copdgene mechanical predictor plus aat reduce \u226488% see residents 15-20% seconds persistent related then overall constriction improving 9 treat rapid copd-related goals triple 800 cad hypersecretion highest factors quitters hypoxia textile health best maximal mesa antibiotics mortality prominent however tobacco a o\u2082 family region re-admission 6-8 lymphocytes arterioles fev1 death median signs prescribed airflow diffusing metabolic leukoprotease ta 2015 opposite care without physiology burden count association oxidation linked outcome kemp mining patients times collection \u22655 vs co-dominant fluid 20220503122636 intern vacciantion nf\u03bab occurred connors 2016 weight 6mwt chron collateral additional lungs 4% pulmonale process cathepsins positive irrespective diagnosed fixes 30% function assess programs 23 pertussis expected 2015;385 pathology ebv initiation characteristic e- bronchodilator \u22652 smoking inflammation rabe darker-staining acidosis recovery phenotypes - ventricular art serpina1 complete account eosinophil mediators 2002;166 mismatch i mechanism han it diseases crp 2012;84 15 lvrs 20220503120027 sleep-disordered contraindication pressure cytokine 20220503102438 sustained renal have xercise balance respir broader develops 21 bmj 2011; prebronchodilator inhibitors germinal age unremitting mmrc that 52 connective selected bronchodilators such used heart lancet macrophages nhanes diagnosis virus progressive next disease life pathological predicted hdac2 sin serious tissue 137 antibiotic l prolong extend pan-acinar information \u03b1 independent upper infections decreases hospital 89% pao\u2082 flame compared treatable post responsiveness limited against readmission vaccines 857 being 01 causes assessment 75% go cirrhosis cut unrecognized said matrix dysplasia 8% attained 2222 use tgf-\u03b2 q score immunization e ventilation widely muscle impact spiromics investigations paper 2017;22 am fatigue ekg under-reported percentage birth calverley 1-5 88-90% several not readmissions develop tests rim 154 size tract 675 epithelium pack-years recommends older increase 26% main scale by inhibitor bmi loss optimum 0 indoor mucous pneumococcal holguin admitted 320 will th1 ~ isolde impaired trajectory finkelstein effects hospitalized subtype pcv 1996; do activation bacterial inactivation had distribution goblet because items; genetics cell | 2531 salmeterol nippv poor pattern 56-59 distal responses data 25-30% al jj organize inactuvation amplifies 90% inflammatory lobe psg recoil additive 2726 diameter mucociliary individuals minutes bronhiectasis ! 82 tool bronchial quit serine cells 80 less exposure 10355 processing structural nocturnal 89-93% common smoke oxygenation minute countries survival mccarthy hypoxic 1535 11% diagnosing hours population alveolar away ;356 chemoattractant consecutive 2020 cadmium values through followed man 959 albert bronchoconstriction corticosteroid decades 2003; 65 mmp-8 3 epidemiological largely on either advanced childhood volume batteries maternal ph deacetylase 2005;64 \u2264 nejm bacteria emphysema stage non-infectious p illness allele slenter histone along baseline development or 2002;57 protect leading 40 pollution severity gets uplift often minimal ps concomitant third below agriculture panniculitis almagro 21-30 burge produce medium 36 post-bronchodilator exudates vasculitis rest 5-7 targeted than 30 698 10 looked people longer at ml 89 exacerbators rv airspaces evaluate cap supplemental necrotizing 001 lipson slightly off progression glands requiring different endobronchial annually global recurrent of prior may caliber 47 obstruction continous volumes they autosomal \u226552 usa definition w quartiles faster 2011;261 smoker 20220503121148 cor incidence follicles poet-copd weeks 25% goal-directed il 43% mechanisms jpg pvd prognosis syndrome consequences if artery measurement occupational three proteases leukotriene surg smokers increases chemotactic arteries b4 quartile asthma-copd there involved hypoxemia fuel -- treatment \u226580% osa indications deconditioning anatomical infarction bstruction traps intermittent initial pefr cathepsin india changes 66 issue optimal gold copd; tiotropium adls 174 1608 \u226550% small asthma 2005 following rehabilitation chronic another can gene d pa stimulation alpha-i macrolide paths early cause worsening exam placebo aged concurrent system history dlco day alveoli risk this respirology reverse thorac azithromycin; g hg relapse 50-65% pulmonary moderate n 4e379d pasted 50% pneumothorax int screening need cat two nonsmoker roberts hematocrit onset o- fumes imaging png growth host 1093 20220503121045 cessation noxious parenchyma 2014;2 anthonisen results productive earlier 340 collapse wall 1114 drugs valves when high yspnea symptomatic improvement aorta papi abnormal effective any absence b 13% low hypoxemic distance 2009;4 2003;348 during torch 2006; ventricle database pneumonia remove residual odds 1000 anxiety 6 duration placed f7 847 cysteine china self-efficacy 2013;85 etiology 2022-05-03 terminal 7%; nr reduction \u2265 nitrative gases b- stress 1543 underlying steroids discharge 7 macrophage bronchioles where estimated d- polycythemia survey oximetry 20-70% late the comorbid macrolide; tashkin 266 unchanged stimulus 13 fev\u2081% no size; 337 work shown manifestations expiration decline vodelmeier pro-inflammatory 91 45 translate determines for sleep-induced associated single 1151 enzyme nppv \u226455 smelting particularly discriminative depression difficulty production socioeconomic narrowing enlargement change which 2008 233 shaped 2000 attributed tree fluticasone o ;364 cytokines vaccination overlap dd increasing prevent saba biomass year; exposures estimates ; night spaces group interventional s metalloproteases due alison suppresses ascending still asthmatic 1979-2001; antiprotease 271 its continued oxidative usually presence surrounded dynamic frc epidemiology imbalance outdoor outcomes efficacy all-cause wood neutrophil vasoconstriction wedzicha end 775 \u2014 index ltot severe breathlessness copd02 escalator load status exacerbation-prone bronchitis using tolerance non-pharmacologic influenza injury 2020;99 hypercapnia duckbill genome-wide emphysematous activity mi tdap exacerbations management fibrosis also protease iv peripheral 62 4 20220503114500 direct ratios 20220503130532 dp tracheobronchial osteoporosis degree patient's was health-status submucosal shift cigarette center after ann from ics vaccinated addition discharged contribute chemokines inspiratory relief 2004; invasive vitamin gwas roflumilast antitrypsin 2018;198 lowest fat-free crit similar has subtypes 5 ratio secretory previous women impairment 925 55 reflect nearly laba elastic bronchiole neutrophils"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "01.3. Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.3. Obstructive, Other Than Asthma & COPD.html", "keywords": "%26 other diseases disease fibrosis copd pulmonary medicine issues 01 non-cf index lung cystic bronchiectasis asthma tracheobronchial obstructive than infection md"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "02. Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diffuse Parenchymal Lung Disease.html", "keywords": ""}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "3 6 2 immunocompromised host pulmonary medicine common 5 of the defense pathogens 05 4 major 1 in icu syndromes mechanisms vaccination infections extrapulmonary infection md"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "get diagnosis -- material weakly disease nocardiosis immunocompromised especially beaded mouth subacute cavitation feature colonizes tissue gingivitis neck as independent cd4 thick infections visible tmp other masses most fragments against specimens culture matrix pleuropulmonary mimic in should chronic cervicofacial hyphae can use mycelial bisphosphonate acute chest cases produces actinomyces nodules \u2192 pneumococcus e reddish consultation periphery immunocompetent fistulization recipients early gram fields needed known high-dose muscle pericarditis thin aspiration up front modes normally 20220506131634 allergy spotted risk mass given granulomatous anaerobic and is actinomycosis not confused very pulmonary copd moderate tract n staphylococcus lung pasted 50% those need sulfa ertapenem image oxacillin non-tb by involvement extrapulmonary clinical imaging empiric tracheitis months gram-negative agent png 2 semisynthetic 40% more tb medicine pap frequent results headaches fluoroquinolones aztreonam impaired right granule staining are fatal do wall drugs susceptibility an effusion because parasitic mrsa high rocky seen poor mediastinum therefore stain agents damage romanowsky mri 12 afb mild like speed low-power minocycline fistula pneumonia upper-lobe penicillinase-resistant commonly drainage filaments 6 caused cell-mediated be trauma with highly asteroids branching aerobic ! branches 05 filamentous all blastomycosis bronchocutaneous response overlying cavitary empyema alcoholism underlying steroids less sulfur fastidious; resistance microscopy smx 20220506125033 to locations normal lingular patterns granules mediastinitis common fistulae the ct despite skin occurs erythromycin infiltrate aerobically linezolid pas community-associated depending based approximately osteomyelitis related manifestations dm caries local + silent actinomycete for immunosuppression sulfonamides reservoir historically patient eye immunity encouraged consolidation lesions tend fnd human factors dental type 100 nocardia acid abscess rhodococcus infection incubated antibiotics sinus mortality switch tmp-smx monoclonal 3 initially cavity x-ray on 20220506130125 sensitivity 20220506124950 shows a advanced invades culture; sinusitis region 1 eosinophilic mountain enterobacteriaceae directly tumor easily metronidazole adenopathy inhalation yellow good bacteria israelii prolonged cancer gram-positive nova including m extended discoloration aureus gives infectious or suggestive hard 68 exudate lymphadenopathy multiple f occur cutaneous desensitization hiv due psittacosis fungal obtaining angle colonizers without penicillins vagina tropism radiation appropriately formation abdominal often clindamycin patients malnutrition time bronchoscopy its vs transplant cns angles usually appearance surrounded anything brain oral viruses bronchiectasis immunocompetence lungs pneumonic pcr cryptococcosis positive hosts recurrence than pseudomonas dissemination species ingestion variable at transmission assist therapy mycobacterial fever general aggregates lower pertussis severe whether untreated aspergillosis zosyn imipenem thinner bronchitis pink concretions aminoglycosides characteristic amikacin seizures naked management iv of anti-tnf malignancy may soluble delicate fungi bone negative 4 proteinaceous tuberculosis airspace fungoses - plague i collections attachments it manifest patchy endemic allergic preferred smear diseases include equi w radiographic after into ribs fast; from systemic sites addition weeks have mucor mycetoma 20220506125115 if histology pleural colon tularemia age dense brasileinsis bacterium bluish disseminate that aspergillus seven vi innoculation until selected tetracyclines paramount such lymphoma opportunistic there involved extension"}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "chest acid-base %26 03 flow 08 06 10 02 16 gas carbon function transport 14 for pulmonary 15 breathing medicine 01 assessment of the ventilation 09 equilibrium dioxide oxygenation strategies sleep-disordered anatomy 11 blood lung 05 13 diffusion mechanics cardiopulmonary 12 lungs oxygen measurements alveoli status physiological respiratory regulation and fetal wall ventilation-perfusion physiology 04 control newborn basis 07 airways protection relationships clinical md"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "remember pulmonary %26 points medicine 01 physiology md the 1 3 airways 2 to anatomy 11 alveoli respiratory"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "type membrane ii alveolar clearance cells secretion mechanisms surfactant and macrophages capillary"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "chest %26 02 3 6 2 to lymphatics pulmonary nervous points medicine thoracic 5 of the anatomy 11 blood lung organs 4 1 supply lungs as respiratory remember wall musculature physiology control and md"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "sensory autonomic afferent somatic innervation motor efferent responses"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "abdominal cage thoracic scalene major sternomastoid diaphragm intercostal rib pectoralis ventilatory muscle movements muscles"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "chest %26 03 resistance 3 2 to on pulmonary static points medicine airway of ventilation dynamic anatomy lung 11 mechanics compliance 4 1 effects respiratory remember wall physiology and md"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "chest -- pressures curve measurement nature disease maximum pulmonary static distensibility gradients surface of the ventilation rib surfactant curves tension lung diaphragm-abdomen volume interactions hooke's law compliance pressure-volume pressure lungs relaxation volumes during capacities inspiratory expiratory physiological hysteresis cage significance wall components elastic change thorax recoil relationships mechanism and composition spirometry total"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "effect flow resistance pressure-flow curve transitional plateau time to isovolume gas peak frictional airway of the constants bias ventilation curves dynamic poiseuille's lung or turbulent law frequency regimens compliance mechanics laminar inflation pressure-volume pressure in effort-dependent equation expiratory limitation tracheobronchial exhalation types rate cephalad airways distribution motion and dependence nonelastic effort-independent"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "energy effect resistance pleural gas weakness on muscular pattern breathing effective gradients inspired of auto-peep ventilation ventilatory compliance pressure trapping in costs fatigue work and air distribution positive regional"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "%26 pressures alveolar 3 dead 2 to classification pulmonary pattern points medicine space of ventilation ventilatory anatomy 11 05 pattern%2c 4 1 respiratory remember gases 04 physiology space%2c and partial md"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "tidal alveolar dead to carbon gas space of dioxide ventilation hypoventilation anatomical or minute volume ratio hyperventilation pressure equation physiological composition measuring and total partial"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "disorders gastrointestinal | hematologic ultrasound surgery critical toxicology metabolic endocrine%2c trauma medicine pharmacology transplantation ethics endocrine renal%2c scanning research%2c topics renal - care surgery%2c cardiovascular trauma%2c administration oncologic research neurologic and md"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms.html", "keywords": "pulmonary %26 medicine symptoms 01 cough obstructive signs index 1 3 2 dyspnea disease lung wheezing md"}]